Comparison of the effect of different short chain fatty acids on the growth and differentiation of human colonic carcinoma cell lines in vitro

Cell Biology International

Volumn 21, Issue 5, 1997, Pages 281-287

  Siavoshian, Samila ^a   Blottière, Hervé M ^b   Le Foll, Eric ^a   Kaeffer, Bertrand ^b   Cherbut, Christine ^b   Galmiche, Jean Paul ^a  

^a HÔTEL DIEU   (France)

^b CEMAGREF   (France)

Author keywords

Butyrate; Colon; Differentiation; Proliferation; Short chain fatty acids

Indexed keywords

ACETIC ACID; ALKALINE PHOSPHATASE; BUTYRIC ACID; DIPEPTIDYL PEPTIDASE IV; HEXANOIC ACID; ISOBUTYRIC ACID; PROPIONIC ACID; SHORT CHAIN FATTY ACID; VALERIC ACID;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN CACO 2; COLON CARCINOMA; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY;

EID: 0031148018     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1006/cbir.1997.0153     Document Type: Article

References (34)

1. Annunziato AT, Eason MB, Perry CA. Relationship between methylation and acetylation of arginine-rich histones in cycling and arrested HeLa cells. Biochemistry. 34:1995;2916-2924.
2. Blottière HM, Zennadi R, Grégoire M, Aillet G, Denis MG, Meflah K, LePendu J. Analysis of the relationship between stage of differentiation and NK/LAK susceptibility of colon carcinoma cells. Int J Cancer. 53:1993;409-417.
3. Boffa LC, Gruss RJ, Allfrey VG. Manifold effect of sodium butyrate on nuclear function. Selective and reversible inhibition of phosphorylation of histones H1 and H2A and impaired methylation of lysine and arginine residues in nuclear protein fractions. J Biol Chem. 256:1981;9612-9621.
4. Boffa LC, Lupton JR, Mariani MR, Ceppi M, Newmark HL, Scalmati A, Lipkin M. Modulation of colonic epithelial cell proliferation, histone acetylation, and luminal short chain fatty acids by variation of dietary fiber (wheat bran) in rats. Cancer Res. 52:1992;5906-5912.
5. Boffa LC, Mariani MR, Parker MI. Selective hypermethylation of transcribed nucleosomal DNA by sodium butyrate. Exp Cell Res. 211:1994;420-423.
6. Brasaemle DL, Attie AD. Microelisa reader, quantitation of fixed, stained, solubilized cells in microtitre dishes. Biotechniques. 6:1988;418-419.
7. Buquet-Fagot C, Lallemand F, Charollais RH, Mester J. Sodium butyrate inhibits the phosphorylation of the retinoblastoma gene product in mouse fibroblasts by a transcription-dependent mechanism. J Cell Physiol. 166:1996;631-636.
8. Cousens LS, Gallwitz D, Alberts BM. Different accessibilities in chromatin to histone acetylase. J Biol Chem. 254:1979;1716-1723.
9. Cummings JH, Pomare EW, Branch WJ, Naylor CPE, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 28:1987;1221-1227.
10. El Oufir L, Flourié B, Bruley des Varannes S, Barry JL, Cloarec D, Bornet F, Galmiche JP. Relations between transit time, fermentation products, and hydrogen consuming flora in healthy humans. Gut. 38:1996;870-877.
11. Gamet L, Daviaud D, Denis-Pouxviel C, Remesy C, Murat JC. Effects of short-chain fatty acids on growth and differentiation of the human colon-cancer cell line HT-29. Int J Cancer. 52:1992;286-289.
12. Gong J, Li X, Traganos F, Darzynkiewicz Z. Expression of G1 and G2 cyclins measured in individual cells by multiparameter flow cytometry: A new tool in the analysis of the cell cycle. Cell Prolif. 27:1994;357-371.
13. Hagopian HK, Riggs MG, Swartz LA, Ingram VM. Effect of n-butyrate on DNA synthesis in chick fibroblasts and HeLa cells. Cell. 12:1977;855-860.
14. Hague A, Elder DJE, Hicks DJ, Paraskeva C. Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer. 60:1995;400-406.
15. Harb J, Vavasseur F, Chadeneau C, Denis M, Meflah K. Expression of alkaline phosphatase in murine lymphoma cells. Biochem Biophys Res Commun. 177:1991;125-133.
16. Herold KM, Rothberg PG. Evidence for a labile intermediate in the butyrate induced reduction of the level of c-myc RNA in SW837 rectal carcinoma cells. Oncogene. 3:1988;423-428.
17. Heruth DP, Zirnstein GW, Bradley JF, Rothberg PG. Sodium butyrate causes an increase in the block to transcriptional elongation in the c-myc gene in SW837 rectal carcinoma cells. J Biol Chem. 268:1993;20,466-20,472.
18. Kawanishi M, Ito Y. Effect of short-chain fatty acids on Epstein-Barr virus early and viral capsid antigen induction in P3HR-1 cells. Cancer Lett. 11:1980;129-132.
19. Kruh, J, Defer, N, Tichonicky, L, 1994, Effect of butyrate on cell proliferation and gene expression, Physiological and Clinical Aspects of Short Chain Fatty Acids, Cambridge University Press.
20. Langdon SP, Hawkes MM, Hay FG, Lawrie SS, Schol DJ, Hilgers J, Leonard RCF, Smyth JF. Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines. Cancer Res. 48:1988;6161-6165.
21. Reese DH, Gratzner HG, Block NL, Politano VA. Control of growth, morphology, and alkaline phosphatase activity by butyrate and related short-chain fatty acids in the retinoid-responsive 9-1C rat prostatic adenocarcinoma cell. Cancer Res. 45:1985;2308-2313.
22. Riggs MG, Whittaker RG, Neumann JR, Ingram VM. n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells. Nature. 268:1977;462-464.
23. Rowe WA, Bayless TM. Colonic short chain fatty acids: fuel from the lumen? Gastroenterology. 103:1992;336-337.
24. Samuels HH, Stanley F, Casanova J, Shao TC. Thyroid hormone nuclear receptor levels are influenced by the acetylation of chromatin-associated proteins. J Biol Chem. 255:1980;2499-2508.
25. Scheppach WM, Bartram P, Richter A, Richter F, Liepold H, Dusel G, Hofstetter G, Ruthlein J, Kasper H. Effect of short-chain fatty acids on the human colonic mucosa in vitro. J Parenter Enteral Nutr. 16:1992;43-48.
26. Scheppach WM, Sommer H, Kirchner T, Paganelli GM, Bartram P, Christl S, Richter F, Dusel G, Kasper H. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology. 103:1992;51-56.
27. Sealy L, Chalkley R. The effect of sodium butyrate on histone modification. Cell. 14:1978;115-121.
28. Siavoshian S, Blottière HM, Bentouimou N, Cherbut C, Galmiche JP. Butyrate enhances major histocompatibility complex class I and HLA-DR antigen expression on differentiated human intestinal epithelial cells. Eur J Clin Invest. 26:1996;803-810.
29. Siavoshian S, Blottière HM, Cherbut C, Galmiche JP. Butyrate stimulates cyclin D and p21 and inhibits cyclin-dependent kinase 2 expression in HT-29 colonic epithelial cells. Biochem Biophys Res Commun. 232:1997;169-172.
30. Souleimani A, Asselin C. Regulation of c-myc expression by sodium butyrate in the colon carcinoma cell line Caco-2. FEBS Lett. 326:1993;45-50.
31. Takenaga K. Effect of butyric acid on lung-colonizing ability of cloned low-metastatic Lewis lung carcinoma cells. Cancer Res. 46:1986;1244-1249.
32. Tallman JF, Smith CC, Henneberry RC. Induction of functional β-adrenergic receptors in HeLa cells. Proc Natl Acad Sci U.S.A. 74:1977;873-877.
33. Whitehead RH, Young GP, Bhathal PS. Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM1215). Gut. 27:1986;1457-1463.
34. Young, GP, Gibson, PR, 1994, Butyrate and the human cancer cell. Physiological and Clinical Aspects of Short Chain Fatty Acids. Cummings, JHRombeau, JLSakata, T, Cambridge University Press.